Antibodies

16 Apr 2008 Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting
16 Apr 2008 Data presented at the 60th Annual Meeting of the American Academy of Neurology offers additional support for plasma exchange as a potential tool to accelerate Tysabri (R) removal
16 Apr 2008 HUMIRA(R) received approval for the treatment of rheumatoid arthritis in Japan
16 Apr 2008 Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
16 Apr 2008 Human Genome Sciences Advances Oncology Portfolio
15 Apr 2008 Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
15 Apr 2008 MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
15 Apr 2008 Seattle Genetics Presents Preclinical Data on its Antibody-Drug Conjugate Technology and SGN-33 Program at AACR
15 Apr 2008 Preclinical data presented for Active Biotech's ANYARA technology
15 Apr 2008 Preclinical Study Presented at AACR Annual Meeting Shows Peregrine's Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
15 Apr 2008 Amgen Presents Preclinical and Clinical Data from Oncology Programs
14 Apr 2008 Lpath Submits Investigational New Drug Application for iSONEP(TM)
14 Apr 2008 Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies
14 Apr 2008 Immunomedics Reports Veltuzumab Enhances Radioimmunotherapy With Epratuzumab in Lymphoma Model
14 Apr 2008 Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
14 Apr 2008 PDL BioPharma Announces Data Presentations for Antibody Pipeline Products
14 Apr 2008 Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
14 Apr 2008 Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies
14 Apr 2008 Genentech and Biogen Idec Announce Top-Line Results from a Phase II/III Clinical Trial of Rituxan in Primary-Progressive Multiple Sclerosis
13 Apr 2008 U3 Pharma achieves preclinical proof of concept for U3-1287 (AMG 888)
10 Apr 2008 Glenmark completes preclinical development for initiating Phase I trials for GBR 500 – a monoclonal antibody for inflammation
09 Apr 2008 Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
09 Apr 2008 Phase II Study of IMC-A12 for Advanced Head and Neck Cancer Commences Patient Enrollment
09 Apr 2008 Seattle Genetics Highlights SGN-70 at AAI Annual Meeting
09 Apr 2008 CuraGen Advances CR011-vcMMAE into Phase II

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top